Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus

Jun Cheng; Wen Zhang; Xiaohui Zhang; Fei Han; Xiayu Li; Xuelin He; Qun Li; Jianghua Chen

doi:10.1001/jamainternmed.2014.348

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus

JAMA Internal Medicine ◽

10.1001/jamainternmed.2014.348 ◽

2014 ◽

Vol 174 (5) ◽

pp. 773 ◽

Cited By ~ 149

Author(s):

Jun Cheng ◽

Wen Zhang ◽

Xiaohui Zhang ◽

Fei Han ◽

Xiayu Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Cardiovascular Events ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

All Cause Mortality ◽

Patients With Diabetes ◽

Receptor Blockers

Download Full-text

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.06.215 ◽

2016 ◽

Vol 220 ◽

pp. 462-466 ◽

Cited By ~ 13

Author(s):

Yi-Chun Kuan ◽

Kuang-Wei Huang ◽

Der-Jen Yen ◽

Chaur-Jong Hu ◽

Cheng-Li Lin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Dementia Risk ◽

Patients With Diabetes ◽

Receptor Blockers

Download Full-text

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis

Kidney & Blood Pressure Research ◽

10.1159/000489913 ◽

2018 ◽

Vol 43 (3) ◽

pp. 768-779 ◽

Cited By ~ 9

Author(s):

Kanran Wang ◽

Jinbo Hu ◽

Ting Luo ◽

Yue Wang ◽

Shumin Yang ◽

...

Keyword(s):

Systematic Review ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

All Cause Mortality ◽

Patients With Diabetes ◽

Receptor Blockers

Download Full-text

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke

Journal of Hypertension ◽

10.1097/hjh.0000000000000804 ◽

2016 ◽

Vol 34 (3) ◽

pp. 567-575 ◽

Cited By ~ 2

Author(s):

Chia-Jen Shih ◽

Hung-Ta Chen ◽

Pei-Wen Chao ◽

Shu-Chen Kuo ◽

Szu-Yuan Li ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Cardiac Events ◽

Converting Enzyme Inhibitors ◽

Adverse Cardiac Events ◽

Patients With Diabetes ◽

Receptor Blockers ◽

Prior Stroke

Download Full-text

Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus

Medicine ◽

10.1097/md.0000000000010256 ◽

2018 ◽

Vol 97 (15) ◽

pp. e0256 ◽

Cited By ~ 4

Author(s):

Xiaodan lv ◽

Yingshi Zhang ◽

Yixuan Niu ◽

Qi Song ◽

Qingchun Zhao

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Hypertensive Patients ◽

Receptor Blockers

Download Full-text

Bayesian Meta-Analysis of Tissue Angiotensin-Converting Enzyme Inhibitors for Reduction of Adverse Cardiovascular Events in Patients with Diabetes Mellitus and Preserved Left Ventricular Function

Journal of the CardioMetabolic Syndrome ◽

10.1111/j.1559-4572.2008.07128.x ◽

2008 ◽

Vol 3 (1) ◽

pp. 45-52 ◽

Cited By ~ 2

Author(s):

Christopher D. Lang ◽

Rohit R. Arora ◽

Sandeep A. Saha ◽

Janos Molnar

Keyword(s):

Diabetes Mellitus ◽

Cardiovascular Events ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Left Ventricular ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Patients With Diabetes ◽

Tissue Angiotensin

Download Full-text

Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs

Journal of the American Pharmacists Association ◽

10.1331/japha.2010.09071 ◽

2010 ◽

Vol 50 (4) ◽

pp. 527-531 ◽

Cited By ~ 8

Author(s):

Yi Yang ◽

Vennela Thumula ◽

Patrick F. Pace ◽

Benjamin F. Banahan ◽

Noel E. Wilkin ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Medicare Part D ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Part D ◽

Patients With Diabetes ◽

Risk Patients ◽

Receptor Blockers

Download Full-text

The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes

Journal of Clinical Hypertension ◽

10.1111/jch.12647 ◽

2015 ◽

Vol 18 (3) ◽

pp. 200-206 ◽

Cited By ~ 2

Author(s):

Raj Padwal ◽

Mu Lin ◽

Dean T. Eurich

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Patients With Diabetes ◽

Receptor Blockers

Download Full-text

Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers for Prevention and Treatment of Nephropathy Associated with Type 2 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.2005.25.11.1602 ◽

2005 ◽

Vol 25 (11) ◽

pp. 1602-1620 ◽

Cited By ~ 13

Author(s):

David B. Hughes ◽

Mark L. Britton

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Prevention And Treatment ◽

Receptor Blockers

Download Full-text

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Effectively and Directly Potentiate Superoxide Scavenging by Polymorphonuclear Leukocytes from Patients with Type 2 Diabetes Mellitus

The American Journal of the Medical Sciences ◽

10.1097/00000441-200505000-00002 ◽

2005 ◽

Vol 329 (5) ◽

pp. 222-227 ◽

Cited By ~ 9

Author(s):

Toshihiko Inukai ◽

Noboru Yoshida ◽

Sadao Wakabayashi ◽

Yoshihisa Inukai ◽

Rika Matsutomo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Polymorphonuclear Leukocytes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Microalbuminuria in type 1 and type 2 diabetes mellitus: Evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy

Current Hypertension Reports ◽

10.1007/s11906-002-0069-3 ◽

2002 ◽

Vol 4 (5) ◽

pp. 387-393 ◽

Cited By ~ 37

Author(s):

Hans-Henrik Parving ◽

Peter Hovind

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text